Scholtz & Company’s Cigna CI Stock Holding History

Scholtz & Company’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,448	Closed	-$1.47M	–	36
2022 Q4	$1.47M	Sell	4,448 -225	-5%	-$71.2K	1.04%	25
2022 Q3	$1.42M	Buy	+4,673	New	+$1.32M	1.01%	27

Other funds holding CI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Scholtz & Company's CI Position: Q1 2023 in Review

Scholtz & Company sold out of Cigna (CI) in Q1 2023, closing a stake of 4,448 shares — an estimated $1.47M sold.

Scholtz & Company first reported a position in CI in Q3 2022 and held it in 2 quarters. The position peaked at $1.47M in Q4 2022. 1,485 funds tracked by Wall St. Rank hold CI as of Q1 2023.

Scholtz & Company reported no remaining Cigna position as of Q1 2023 after selling out during the quarter.
Scholtz & Company sold 4,448 Cigna shares in Q1 2023, an estimated $1.47M.
Scholtz & Company first reported a position in Cigna in Q3 2022 and held it in 2 quarters.
Scholtz & Company's Cigna position peaked at $1.47M in Q4 2022.
1,485 funds tracked by Wall St. Rank held Cigna as of Q1 2023.

Based on Scholtz & Company's 13F filing for Q1 2023, filed 15 May 2023.